MONTEFUSCO, Enrico
 Distribuzione geografica
Continente #
NA - Nord America 2.935
AS - Asia 990
EU - Europa 544
SA - Sud America 168
AF - Africa 30
Totale 4.667
Nazione #
US - Stati Uniti d'America 2.892
SG - Singapore 367
CN - Cina 175
VN - Vietnam 162
IT - Italia 139
BR - Brasile 129
IN - India 91
HK - Hong Kong 90
SE - Svezia 72
DE - Germania 61
UA - Ucraina 51
FI - Finlandia 42
BD - Bangladesh 40
FR - Francia 37
BG - Bulgaria 33
RU - Federazione Russa 31
CA - Canada 29
GB - Regno Unito 24
BE - Belgio 16
AR - Argentina 13
JP - Giappone 12
IQ - Iraq 10
RO - Romania 10
EC - Ecuador 7
IE - Irlanda 7
ZA - Sudafrica 7
NL - Olanda 6
CL - Cile 5
EG - Egitto 5
ID - Indonesia 5
JM - Giamaica 5
MA - Marocco 5
PK - Pakistan 5
TN - Tunisia 5
KR - Corea 4
NP - Nepal 4
PH - Filippine 4
PY - Paraguay 4
VE - Venezuela 4
AT - Austria 3
AZ - Azerbaigian 3
CZ - Repubblica Ceca 3
SA - Arabia Saudita 3
TG - Togo 3
CO - Colombia 2
DZ - Algeria 2
ES - Italia 2
GE - Georgia 2
GR - Grecia 2
JO - Giordania 2
KE - Kenya 2
MX - Messico 2
PE - Perù 2
PL - Polonia 2
TR - Turchia 2
AE - Emirati Arabi Uniti 1
BB - Barbados 1
BM - Bermuda 1
BO - Bolivia 1
BS - Bahamas 1
BY - Bielorussia 1
CR - Costa Rica 1
EE - Estonia 1
ET - Etiopia 1
HN - Honduras 1
KG - Kirghizistan 1
KZ - Kazakistan 1
LB - Libano 1
LT - Lituania 1
MY - Malesia 1
PA - Panama 1
PS - Palestinian Territory 1
TH - Thailandia 1
TT - Trinidad e Tobago 1
TW - Taiwan 1
UY - Uruguay 1
UZ - Uzbekistan 1
Totale 4.667
Città #
Singapore 214
Fairfield 198
San Jose 168
Ashburn 164
Chandler 123
Houston 94
Hong Kong 87
Seattle 80
Woodbridge 79
Dallas 77
Wilmington 68
Beijing 57
Cambridge 53
Hanoi 49
Ho Chi Minh City 48
Princeton 36
Santa Clara 34
Sofia 32
Plano 31
Ann Arbor 29
Lauterbourg 29
Los Angeles 29
Rome 29
San Paolo di Civitate 25
Jacksonville 23
Buffalo 22
Boston 21
Lawrence 21
Munich 21
Frankfurt am Main 19
Milan 19
Brussels 16
The Dalles 16
Millbury 15
New York 15
Norwalk 14
Da Nang 13
Toronto 12
Redondo Beach 11
San Diego 10
Tokyo 10
Hillsboro 9
Moscow 9
Orem 8
São Paulo 8
Dublin 7
Falkenstein 7
Haiphong 7
Helsinki 7
Ottawa 7
Dearborn 6
Des Moines 6
Federal 6
Nuremberg 6
Rio de Janeiro 6
Andover 5
Biên Hòa 5
Bologna 5
Can Tho 5
Charlotte 5
Chicago 5
Columbus 5
Falls Church 5
Guangzhou 5
Hefei 5
Johannesburg 5
Miano 5
Turku 5
Yubileyny 5
Boardman 4
Bremen 4
Casablanca 4
Chennai 4
Nanjing 4
Palermo 4
Piracicaba 4
Poplar 4
Santiago 4
Southend 4
Trento 4
Tây Ninh 4
Amsterdam 3
Baghdad 3
Brasília 3
Brooklyn 3
Erbil 3
Lomé 3
London 3
Oklahoma City 3
Prague 3
Recife 3
San Mateo 3
Tianjin 3
Ahmedabad 2
Algiers 2
Antwerp 2
Baku 2
Burlington 2
Bühl 2
Bến Tre 2
Totale 2.378
Nome #
Intrathecal anti-CD20 antibody: an effective and safe treatment for leptomeningeal lymphoma. 1.274
Anagrelide in Essential Thrombocythemia (ET): Results from 150 patients over 25 years by the ``Ph1-negative Myeloproliferative Neoplasms Latium Group{''} 161
High-dose hydroxyurea in the treatment of poor-risk myeloid leukemias 155
Comparison between patients with Philadelphia-positive chronic phase chronic myeloid leukemia who obtained a complete cytogenetic response within 1 year of imatinib therapy and those who achieved such a response after 12 months of treatment 137
Imatinib in very elderly patients with chronic myeloid leukemia in chronic phase: a retrospective study. 135
Age influences initial dose and compliance to imatinib in chronic myeloid leukemia elderly patients but concomitant comorbidities appear to influence overall and event-free survival. 132
Hammersmith score application identifies chronic myeloid leukemia patients with poor prognosis before treatment with second-generation tyrosine kinase inhibitors 123
Spleen enlargement is a risk factor for thrombosis in essential thrombocythemia: Evaluation on 1,297 patients 123
Chelation efficacy and erythroid response during deferasirox treatment in patients with myeloproliferative neoplasms in fibrotic phase 120
Male patients with chronic myeloid leukemia treated with imatinib involved in healthy pregnancies: Report of five cases 116
Acute promyelocytic leukemia (APL) in very old patients: real-life behind protocols 112
Allogeneic Transplant in Acute Myeloid Leukemia (AML) According to the Policy of the Rome Transplant Network (RTN): An Intention-to-Treat Analysis 110
Survival of Patients with High Risk Hematological Malignancy after Allogeneic Transplant from HLA Identical Siblings Is Comparable to That of Patients Transplanted from Haploidentical, Unmanipulated Bone Marrow Donor: Results of a Matched-Pair Analysis from the Rome Transplant Network 108
Dasatinib is safe and effective in unselected chronic myeloid leukaemia elderly patients resistant/intolerant to imatinib 108
A phase II study of VP-16, intermediate-dose Ara-C and carboplatin (VAC) in advanced acute myelogenous leukemia and blastic chronic myelogenous leukemia 107
Impact of BCR-ABL mutations on response to dasatinib after imatinib failure in elderly patients with chronic-phase chronic myeloid leukemia. 107
Identification of a potential “hotspot” DNA region in the RUNX1 gene targeted by mitoxantrone in therapy-related acute myeloid leucemia with t(16;21) translocation 106
Acute Promyelocytic Leukemia (APL) in Very Elderly Patients: Real-Life behind Protocols 101
Ten-year follow-up of a single center prospective trial of unmanipulated peripheral blood stem cell autograft and interferon-alpha in early phase chronic myeloid leukemia 101
Thrombosis and survival in essential thrombocythemia: A regional study of 1,144 patients 99
HBV AND NON HODGKIN'S LYMPHOMA 96
Low absolute lymphocyte count is a poor prognostic factor in diffuse-large-B-cell-lymphoma 88
Erythropoietin treatment of idiopathic myelofibrosis. 87
Ph-negative and bcr-negative atypical chronic myelogenous leukemia: biological features and clinical outcome 82
Hbv Markers In Acute Leukaemia Patients Treated With Myelosuppressive Chemotherapy: A Monocentric Experience 80
The Role of Previous Thrombotic Events in Patients with Essential Thrombocythemia: The Earlier the Worse? 75
Etoposide, ARA-C a dosi intermedie e Carboplatino (VAC): un nuovo programma di chemioterapia attivo nella leucemia mieloide acuta (LMA) refrattaria e nella crisi blastica di leucemia mieloide cronica (LMC-CB) 75
Hemoglobin levels and circulating blasts are two easily evaluable diagnostic parameters highly predictive of leukemic transformation in primary myelofibrosis 75
In vitro and in vivo study of treatment with the HDAC inhibitor valproic acid (VPA) in two patients affected by acute myeloid leukaemia post myelodysplastic syndrome 69
High-dose hydroxyurea (High-HY) in the treatment of poor risk acute myeloid leukemia 60
PIPOBROMAN IN POLYCYTHEMIA-VERA PATIENTS - A RETROSPECTIVE ANALYSIS 58
IN VITRO AND IN VIVO STUDY OF TREATMENT WITH THE HDAC INHIBITOR VALPROIC ACID (VPA) IN TWO PATIENTS AFFECTED BY ACUTE MYELOID LEUKAEMIA POST MYELODYSPLASTIC SYNDROME 57
High platelet count at diagnosis is a protective factor for thrombosis in patients with essential thrombocythemia 55
null 51
Three Cases of Therapy-related Acute Myeloid Leukaemia In Patients With Multiple Sclerosis: the Role of Arsenic Trioxide In the Treatment of Secondary Apl 50
null 50
null 46
null 45
Totale 4.734
Categoria #
all - tutte 10.553
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 10.553


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022324 4 17 29 19 58 7 10 23 27 25 27 78
2022/2023357 71 87 32 21 34 45 9 15 27 0 12 4
2023/2024152 21 25 6 13 16 35 0 2 1 5 6 22
2024/20251.614 1.070 84 16 8 29 38 37 22 62 58 38 152
2025/20261.432 157 135 81 119 176 70 178 58 177 108 81 92
2026/202759 59 0 0 0 0 0 0 0 0 0 0 0
Totale 4.734